Icon Pharma manufactures a wide range of Pharmaceutical formulations at its independent, state-of- the-art manufacturing facilities, which also house independent quality control departments and research & development units. We has two fully automated, state-of- the-art independent production units. We are also coming up with a third state of the art sterile facility, specifically targeted for the regulated markets.
Highest priority is given to the quality-control factor and adequate precautions are taken to ensure that there are no lapses on the production front. Our embraces GMP (Good Manufacturing Practice) Standards, including WHO GMP norms laid down by the World Health Organization and cGMP norms laid down in the "Revised Schedule M" by the Drug Controller (General) India, Ministry of Health, and Government of India.
Here are some of the real life images from Ciron's brand new sterile manufacturing facility in compliance with USFDA , EU & PIC/S cGMP requirements.